Wuhu, Anhui Province: A batch of cheap shortage of drugs has gone up in price (with list)

Medicine Network September 11th, September 9th, Wuhu City, Anhui Province, pharmaceutical medical supplies management center issued the "2020 municipal public hospital drug price adjustment public notice."
notice shows that due to fluctuations in drug market prices, resulting in some drug supply is not smooth, in order to ensure the clinical supply of medical institutions, the Municipal Drug Control Center for the city's second, fourth and fifth hospitals to request price adjustment of drugs, in accordance with the relevant documents require the organization of personnel for the first instance, and september 2 to September 8, 2020 to eight Wuhu City public hospitals centralized procurement of drugs in the bid distribution enterprises to make inquiries, will be after the inquiry to comply with the six varieties stipulated in the document.
: 9 September 2020 to 15 September 2020 (complaints accepted on weekdays).
The list of price adjustment varieties is as follows: Saibai Blue query Mi Net drug bidding library data comparison found that, unlike our daily price adjustment announcement, are generally adjusted to a lower place, the above price adjustment varieties are higher, and have a relatively large adjustment.
e.g. potassium chloride slow release tablets 0.5g x 48, the same manufacturer in Anhui before the price was 9 yuan, now adjusted to 14 yuan, up 55.6%; 0.3 yuan, now adjusted to 1.6 yuan, up as much as 433.3%;
these drugs are mostly low-cost drugs, cheap life-saving drugs, and some are often in short supply around the drug catalog.
From the official notice content, the reason for these drug price adjustment is due to the price fluctuations of the drug market (it should be said that the price is too low), resulting in some of the drug supply is not smooth, and these drugs clinically need to ensure the clinical supply of medical institutions, so the appropriate price adjustment.
shortage of cheap medicines is common in fact, in recent years, there have been many cheap drugs, first aid drugs throughout the country there have been shortages, out of stock phenomenon.
, for example, in January this year, Hainan Province's centralized pharmaceutical procurement center issued a notice that 250 drug applications to cancel the network.
Of these 250 drugs, 171 were discontinued due to rising production costs, inability to supply normally, production line modifications, production line stops, etc., 28 were discontinued due to price increases or shortages of API, and 15 were discontinued due to the inverted bid price and cost.
are clearly characterized by the increase in the price of these API products.
e.g. plate blue root particles, is anti-flu Chinese medicine, the flu season demand is huge
also reported that the only life-saving drug for patients with bean-like nuclear degeneration, 2sodium propylene, has been in short supply this year
it is known that the disease is a rare disease, the domestic incidence of the population in about one in 30,000, for the treatment of liver bean-like nuclear degeneration is currently the most effective drug is 2
, according to an August 21 report in the Health Times, the drug has been discontinued for several months and has been in short supply since it was out of stock in March.
Chen Bing, founder of the China Liver Bean-shaped Nuclear Degenerative Rare Disease Care Association, told the Health Times that the main reason for the current shortage of the drug is the environmental protection of API companies and process improvements, but the deeper reason is that the market sales are small.
before the twos sodium propylene sulfur 29 yuan, and then the year before 49.5 yuan, now because of the shutdown, rose to 58 yuan, some were even scrambled to 87, 198 yuan.
In fact, not only twosodium propylene sodium injection, many cheap life-saving drugs, rare disease drugs are in short supply, enterprises are mainly due to enterprises do not have sufficient profit margins, so will lead to two situations, either price increases to maintain production, or stop production.
to solve the shortage of cheap life-saving drugs, we should start from the root cause, balance the relationship between the profits of enterprises and clinical needs, in the appropriate price range, so that enterprises do not lose money, to protect the demand for clinical drugs.
.